BCS CME Satellite Symposium | Evaluation Questionnaire BCS CME Satellite | Evaluation Questionnaire How likely are you to recommend this course to a friend or colleague? * 1 2 3 4 5 (1-Not Likely to 5-Very Likely) I attest that I have completed this educational activity in its entirety. * Yes No Were faculty disclosures made prior to the start of the CME activity? * Yes No Please rate whether the following educational objectives were met. Review the clinical trial data on treatment pathways and associated new/emerging targets for the treatment of patients with HER2-positive breast cancer * Agree Disagree Neutral Discuss the mechanisms of action and clinical role of monoclonal antibodies, tyrosine kinase inhibitors (TKIs), an antibody-drug conjugate (ADC) therapy in the treatment of HER2-positive breast cancer * Agree Disagree Neutral Identify strategies for managing/preventing treatment-related adverse events (TRAEs) and improving outcomes in patients with HER2-positive breast cancer * Agree Disagree Neutral Please rate the projected impact of this activity on your knowledge, competence, performance, and patient outcomes: This activity increased my knowledge. * Yes No No Change This activity increased my competence. * Yes No No Change This activity increased my performance. * Yes No No Change This activity increased my patient outcomes. * Yes No No Change Do you feel the activity was scientifically sound and free of commercial bias or influence? Do you feel the activity was scientifically sound and free of commercial bias or influence? Yes No Comments Please identify how you will change your practice as a result of attending this activity. This activity validated my current practice. No changes will be made. * Yes No Create/revise protocols, policies, and/or procedures * Yes No Change the management and/or treatment of my patients * Yes No Other Please indicate any barriers you perceive in implementing these changes. * Cost Lack of experience Lack of opportunity (patients) Lack of resources (equipment) Lack of administrative support Lack of time to assess/counsel patients Patient compliance issues Lack of consensus or professional guidelines No barriers OtherOther Will you attempt to address these barriers in order to implement changes in your competence, performance, and/or patients' outcomes? * Yes No NA The content of this activity matched my current (or potential) scope of practice. * Yes No Please rate the following faculty - Sunday, September 25th: Course Chair and Moderator - Chau T. Dang, MD (MSKCC) The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous * Agree Disagree Neutral NA Comments Clinical Role of Current and Emerging Treatments for HER2+Metastatic Breast Cancer – VK Gadi, MD, PhD The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous * Agree Disagree Neutral NA Comments Management of Lifestyle Impacting Toxicities – Neil Iyengar, MD The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous * Agree Disagree Neutral NA Comments Managing Lifestyle-Impacting Toxicities - Neil Iyengar, MD of Anti-HER2 Therapy The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous * Agree Disagree Neutral NA Comments Please share any suggestions for future topics. reCAPTCHA If you are human, leave this field blank. Submit Δ